Edition:
India

Dan Levine

Exclusive: FDA faults quality control at Lilly plant making Trump-touted COVID drug

15 Oct 2020

(This Oct. 13 story corrects to show that the federal government, not Eli Lilly, made the decision to pause a clinical trial of the company’s antibody drug, paragraph 10) | Video

Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sources

02 Oct 2020

WASHINGTON The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. | Video

Exclusive: Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflict

24 Sep 2020

A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel's review of COVID-19 vaccines because of her role overseeing a clinical trial for Moderna Inc's candidate, her spokeswoman told Reuters.

Pfizer vaccine trial bets on early win against coronavirus, documents show

18 Sep 2020

Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.

Exclusive: Top FDA official says would resign if agency rubber-stamps an unproven COVID-19 vaccine

22 Aug 2020

A top U.S. health regulator who will help decide the fate of a coronavirus vaccine has vowed to resign if the Trump administration approves a vaccine before it is shown to be safe and effective, Reuters has learned.

RPT-EXCLUSIVE-Top FDA official says would resign if agency rubber-stamps an unproven COVID-19 vaccine

21 Aug 2020

Aug 20 A top U.S. health regulator who will help decide the fate of a coronavirus vaccine has vowed to resign if the Trump administration approves a vaccine before it is shown to be safe and effective, Reuters has learned.

World News